Stay updated on FT516 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the FT516 in Hematologic Malignancies Clinical Trial page.

Latest updates to the FT516 in Hematologic Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new Revision: v3.3.3 entry was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Record History now shows a new revision entry, v3.3.2, and the old revision entry v3.3.1 has been removed.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded revision v3.3.1 to the Record History and removed revision v3.2.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoval of the government funding/operating-status banner from the page; this banner did not affect the trial data or record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check58 days agoChange DetectedNew screenshot shows minor visual/layout tweaks to the Record History page (spacing and header/footer styling) without any changes to the underlying version data or navigation.SummaryDifference0.1%

- Check86 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

Stay in the know with updates to FT516 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT516 in Hematologic Malignancies Clinical Trial page.